文献速递乳腺癌

代谢组学在乳腺癌流行病学研究中的应用:病因学与预防的新视角

Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention.
PubMed 文献 · J Clin Oncol · 2023-11-09

本文综述了代谢组学在基于人群的前瞻性流行病学研究中的应用,通过分析诊断前血液样本识别与乳腺癌风险相关的循环代谢物,并讨论了方法学异质性对结果比较的挑战。结论认为代谢组学有助于提出病因假说,但需更大样本、详细分层信息和重复采样研究来验证发现。

要点

  • 特定脂质和氨基酸是与乳腺癌发生相关的最常见代谢物类别。
  • 由于实验室技术、分析方法、样本量和统计方法异质性,研究间结果比较困难。
  • 需更大样本量、详细绝经状态和乳腺癌亚型信息及重复生物样本研究来验证发现。

核心结论

  • 代谢组学正越来越多地应用于基于人群的研究,以识别与乳腺癌发生相关的新病因学假说和/或机制。
  • 尽管在流行病学应用中取得成功,仍需更大样本量、详细绝经状态和乳腺癌亚型信息以及随时间重复采集的生物样本研究来改善研究间结果比较并增强结果验证,从而实现发现的潜在临床转化。

研究设计与样本

  • 综述评估了将代谢组学分析应用于前瞻性流行病学研究诊断前血液样本,以识别与乳腺癌风险相关的循环代谢物的研究。
  • 综述提供了在此背景下应用和解释代谢组学方法的一些重要考虑。

主要发现

  • 总体而言,特定脂质和氨基酸被指出是与乳腺癌发生相关的最常见代谢物类别。
  • 由于实验室技术、分析方法、样本量和应用统计方法的异质性,研究间结果比较具有挑战性。

局限性

  • 由于实验室技术、分析方法、样本量和应用统计方法的异质性,研究间结果比较具有挑战性。
  • 需要更大样本量、详细绝经状态和乳腺癌亚型信息以及随时间重复采集的生物样本研究来改善研究间结果比较并增强结果验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide an overview on how the application of metabolomics (high-throughput characterization of metabolites from cells, organs, tissues, or biofluids) to population-based studies may inform our understanding of breast cancer etiology. METHODS: We evaluated studies that applied metabolomic analyses to prediagnostic blood samples from prospective epidemiologic studies to identify circulating metabolites associated with breast cancer risk, overall and by breast cancer subtype and menopausal status. We provide some important considerations for the application and interpretation of metabolomics approaches in this context. RESULTS: Overall, specific lipids and amino acids were indicated as the most common metabolite classes associated with breast cancer development. However, comparison of results across studies is challenging because of heterogeneity in laboratory techniques, analytical methods, sample size, and applied statistical methods. CONCLUSION: Metabolomics is being increasingly applied to population-based studies for the identification of new etiologic hypotheses and/or mechanisms related to breast cancer development. Despite its success in applications to epidemiology, studies of larger sample size with detailed information on menopausal status, breast cancer subtypes, and repeated biologic samples collected over time are needed to improve comparison of results between studies and enhance validation of results, allowing potential clinical translation of findings.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. His M, Gunter MJ, Keski-Rahkonen P, et al. Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention. J Clin Oncol. 2023. PMID: 37944067. doi:10.1200/JCO.22.02754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。